🇺🇸 FDA

Drug profile · INN

atezolizumab and hyaluronidase-tqjs

TECENTRIQ HYBREZA

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

atezolizumab and hyaluronidase-tqjs (TECENTRIQ HYBREZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN atezolizumab and hyaluronidase-tqjs
Brand TECENTRIQ HYBREZA
Route INJECTION
Formulation INJECTABLE

Frequently asked questions

What is atezolizumab and hyaluronidase-tqjs?

atezolizumab and hyaluronidase-tqjs (TECENTRIQ HYBREZA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for atezolizumab and hyaluronidase-tqjs?

TECENTRIQ HYBREZA is a marketed brand name for atezolizumab and hyaluronidase-tqjs. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of atezolizumab and hyaluronidase-tqjs?

atezolizumab and hyaluronidase-tqjs has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.